Ausgabe 3/2012
Inhalt (6 Artikel)
Paradoxical and Bidirectional Drug Effects
Silas W. Smith, Manfred Hauben, Jeffrey K. Aronson
Oral Contraceptives and Venous Thromboembolism
Lamberto Manzoli, Corrado De Vito, Carolina Marzuillo, Antonio Boccia, Paolo Villari
How are the Costs of Drug-Related Morbidity Measured?
Hanna Gyllensten, Anna K. Jönsson, Clas Rehnberg, Anders Carlsten
Expectations for Feedback in Adverse Drug Reporting by Healthcare Professionals in the Netherlands
Ingrid Oosterhuis, Florence P.A.M. van Hunsel, Eugène P. van Puijenbroek
The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment
John R. Teerlink, Vicente J. Iragui, Jay P. Mohr, Peter E. Carson, Paul J. Hauptman, David H. Lovett, Alan B. Miller, Ileana L. Piña, Scott Thomson, Paul D. Varosy, Michael R. Zile, John G. F. Cleland, Michael M. Givertz, Marco Metra, Piotr Ponikowski, Adriaan A. Voors, Beth A. Davison, Gad Cotter, Denise Wolko, Paul DeLucca, Christina M. Salerno, George A. Mansoor, Howard Dittrich, Christopher M. O’Connor, Barry M. Massie
Targeting Outpatient Drug Safety
Margaretha F. Warlé-van Herwaarden, Cees Kramers, Miriam C. Sturkenboom, Patricia M.L.A. van den Bemt, Peter A.G.M. De Smet